Gilead study finds remdesivir helps treat some coronavirus patients

Gilead Sciences’ antiviral drug remdesivir showed signs of helping certain coronavirus patients in a study showing better results from a shorter course of treatment, the company said Monday. People with moderate COVID-19 pneumonia who took a five-day treatment of remdesivir were 65 percent more likely to show “clinical improvement” at day 11 than people who […]

Read More

Coronavirus: Gilead says remdesivir trial showed positive results with early treatment

Gilead Sciences provided a possible ray of hope in the fight against coronavirus, when the biotech giant said Wednesday that a trial involving its antiviral drug remdesivir resulted in improved conditions for patients when given a five-day dosage of the medication. Foster City-based Gilead said that the clinical trial involved 397 patients with severe cases […]

Read More

Gilead Claims ‘Positive Data’ to Come From N.I.H. Trial of Remdesivir

Gilead Sciences on Wednesday announced that the company “is aware of positive data” from a federal study of its experimental coronavirus drug, remdesivir. Neither Gilead nor officials at the National Institute of Allergy and Infectious Diseases, sponsor of the federal research, provided further details. A spokeswoman at N.I.A.I.D., part of the National Institutes of Health, […]

Read More

Gilead Withdraws Request for Special Orphan Status on Experimental Virus Treatment

Bowing to criticism that it was exploiting the coronavirus pandemic, the drugmaker Gilead said on Wednesday that it would no longer seek orphan-drug status for remdesivir, an experimental drug that is being tested as a possible treatment. The Food and Drug Administration had only granted the special designation on Monday — which gives drug companies […]

Read More

Coronavirus Patients in Limbo as Gilead Suspends Emergency Drug Access

Overwhelmed by demand for an experimental treatment for coronavirus, the drug maker Gilead abruptly shut down its emergency access program, leaving doctors and families scrambling for answers. The company said it was setting up a broader access program that could try to help more people, but some said the transition is delaying remedies for very […]

Read More

Gilead to Expand Coronavirus Drug Trials to Other Countries

The drug maker Gilead Sciences is expanding its clinical trials of the antiviral drug remdesivir as a possible coronavirus treatment into several countries outside China, the company announced on Wednesday. Two new clinical trials of remdesivir are to begin in March, involving “approximately 1,000 patients at medical centers primarily across Asian countries, as well as […]

Read More